You are viewing the site in preview mode

Skip to main content

Advertisement

Figure 4 | BMC Infectious Diseases

Figure 4

From: Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice

Figure 4

Detection of CAV-2-ROP18 immunization on the antibody response. Serum samples were collected at weeks 0, 2, 4 and 6 post-primary immunization. (A) Determination of specific anti-ROP18 IgG antibodies in the sera of Kunming mice. (B) Determination of the specific anti-ROP18 IgG subclass profile in the sera of the immunized Kunming mice. Results are expressed as means of the OD490 value and standard deviation (n = 5), and statistically significant difference (P < 0.05) are indicated by an asterisk (*).

Back to article page